Gibson Christopher — SEC Form 4 filings
SEC reporting owner CIK 1856369. 57 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2024-05-17 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 31 filings — 2,346,749 shares, $12,798,651 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 128.
- Largest priced transaction: sale of 500,300 shares @ $5.28 ($2,641,584) in RECURSION PHARMACEUTICALS, INC., filed 2025-08-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 47 | — | 43 legs · 2,346,749 sh · $12,798,651 | 123 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Director | 3 | — | — | 5 |
Form 4 filings — Gibson Christopher
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.62 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 74,497 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.08 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 22,821 @ $3.04 | EDGAR |
| 2026-05-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 60,000 @ $0 · Sale (S): 40,000 @ $3.37 · Gift (G): 20,000 @ $0 · Conversion (C): 60,000 (derivative) @ $0 | EDGAR |
| 2026-04-24 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.61 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-04-10 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 57,473 @ $0 · Grant/award (A): 77,842 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.10 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.25 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Gift (G): 20,000 @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 53,913 @ $0 · Grant/award (A): 73,087 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 27,265 @ $3.49 · Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $3.46 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $4.12 · Grant/award (A): 30,346 @ $0 · Tax withholding (F): 10,364 @ $3.56 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $4.47 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 60,000 @ $0 · Sale (S): 40,000 @ $4.25 · Gift (G): 20,000 @ $0 · Conversion (C): 60,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $4.50 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 60,000 @ $0 · Sale (S): 40,000 @ $4.63 · Gift (G): 20,000 @ $0 · Conversion (C): 60,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 40,390 @ $4.14 · Conversion (C): 40,000 @ $0 · Sale (S): 40,000 @ $4.16 · Conversion (C): 40,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 60,000 @ $0 · Sale (S): 40,000 @ $5.21 · Gift (G): 20,000 @ $0 · Conversion (C): 60,000 (derivative) @ $0 | EDGAR |
| 2025-10-24 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 100,000 @ $0 · Sale (S): 100,000 @ $5.70 · Conversion (C): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 120,000 @ $0 · Sale (S): 100,000 @ $6.04 · Gift (G): 20,000 @ $0 · Conversion (C): 120,000 (derivative) @ $0 | EDGAR |
| 2025-09-26 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 100,000 @ $0 · Sale (S): 100,000 @ $4.76 · Conversion (C): 0 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 120,000 @ $0 · Sale (S): 100,000 @ $4.71 · Gift (G): 20,000 @ $0 · Conversion (C): 120,000 (derivative) @ $0 | EDGAR |
| 2025-08-28 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 100,000 @ $0 · Sale (S): 100,000 @ $4.84 · Conversion (C): 100,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 40,390 @ $5.64 | EDGAR |
| 2025-08-13 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 423,666 @ $0 · Sale (S): 500,300 @ $5.28 · Gift (G): 10,000 @ $0 · Conversion (C): 100,000 @ $0 · Sale (S): 100,000 @ $5.28 · Conversion (C): 17,875 @ $0 · +4 more | EDGAR |
| 2025-05-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 36,197 @ $4.25 | EDGAR |
| 2025-03-28 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 138,574 @ $6.04 | EDGAR |
| 2025-03-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.58 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.37 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 17,132 @ $10.64 | EDGAR |
| 2025-02-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.68 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $8.12 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 525,283 @ $0 · Grant/award (A): 16,809 @ $0 · Tax withholding (F): 5,569 @ $7.25 · Grant/award (A): 1,050,567 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.31 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.05 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.16 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.12 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 26,023 @ $6.17 | EDGAR |
| 2024-11-15 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.74 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $7.35 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.16 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.08 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-09-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.04 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.14 · Conversion (C): 20,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-08-30 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-28 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-26 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-23 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Option exercise (M): 5,000 @ $2.48 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 26,082 @ $6.69 | EDGAR |
| 2024-08-09 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 30,000 @ $0 · Sale (S): 30,000 @ $7.10 · Conversion (C): 20,000 @ $0 · Sale (S): 20,000 @ $6.50 · Conversion (C): 30,000 (derivative) @ $0 · Conversion (C): 20,000 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4/A | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 100,000 @ $0 · Conversion (C): 100,000 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Gift (G): 25,000 @ $0 · Conversion (C): 50,000 @ $0 · Sale (S): 50,000 @ $7.48 · Conversion (C): 50,000 @ $0 · Sale (S): 50,000 @ $7.47 · Conversion (C): 50,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-06-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Conversion (C): 25,000 @ $0 · Gift (G): 25,000 @ $0 · Sale (S): 50,000 @ $8.42 · Sale (S): 50,000 @ $9 · Conversion (C): 25,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Tax withholding (F): 26,082 @ $10.01 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →